COMMUNIQUÉS West-GlobeNewswire

-
SIGA Technologies CSO to Speak at The 13th CBRNe Protection Symposium on September 25, 2019
25/09/2019 -
VitalHub Corp. Announces Early Redemption Of $2,219,000 Outstanding Debentures & New Debt Financing
25/09/2019 -
Crinetics Pharmaceuticals to Participate in Cantor Global Healthcare Conference
25/09/2019 -
Dance Biopharm Announces Rebranding to Aerami Therapeutics Reflecting a Broadened Strategic Focus on Inhaled Therapies for Chronic Diseases
25/09/2019 -
AzurRx BioPharma Announces Positive Results from Phase 2 Trial with MS1819 in Cystic Fibrosis Patients
25/09/2019 -
T2 Biosystems Enters into Distribution Agreement to Expand its Innovative Rapid Diagnostic Technologies to Puerto Rico and the U.S. Virgin Islands
25/09/2019 -
Cytokinetics Announces Second Annual Communications Fellowship Program Call for Proposals
25/09/2019 -
Intra-Cellular Therapies Announces Progression to Higher Dose Cohort in ITI-214 Translational Medicine Study in Patients with Heart Failure
25/09/2019 -
RTI Surgical® Showcases Advancements in Spine Portfolio and Clinical Data at NASS 2019
25/09/2019 -
Trillium Therapeutics Appoints Jan Skvarka as President and Chief Executive Officer
25/09/2019 -
Microbix Presenting at Muskoka Capital Conference
25/09/2019 -
Achillion Receives Breakthrough Therapy Designation from FDA for Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria
25/09/2019 -
Rhythm Pharmaceuticals Provides Update on Research and Development Programs
25/09/2019 -
Orchard Therapeutics to Present at the 2019 Cell & Gene Meeting on the Mesa
25/09/2019 -
Summit Therapeutics to Host R&D Day 7 October 2019
25/09/2019 -
Matinas BioPharma Announces Pre-Screening of Patients to Determine Eligibility for Phase 2 ENHANCE-IT Study Against Vascepa®
25/09/2019 -
Teleflex Announces Tenth Anniversary of GuideLiner® Catheter Product Line
25/09/2019 -
Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion
25/09/2019 -
Chi-Med Highlights Presentation of Clinical Data from the Successful SANET-ep Phase III Trial at ESMO Annual Meeting
25/09/2019
Pages